135 related articles for article (PubMed ID: 2178931)
1. Efficacy and safety of simvastatin (alone or in association with cholestyramine). A 1-year study in 66 patients with type II hyperlipoproteinaemia.
Emmerich J; Aubert I; Bauduceau B; Dachet C; Chanu B; Erlich D; Gautier D; Jacotot B; Rouffy J
Eur Heart J; 1990 Feb; 11(2):149-55. PubMed ID: 2178931
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with simvastatin compared with cholestyramine.
Erkelens DW; Baggen MG; Van Doormaal JJ; Kettner M; Koningsberger JC; Mol MJ
Drugs; 1988; 36 Suppl 3():87-92. PubMed ID: 3254824
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin and cholestyramine in the long-term treatment of hypercholesterolaemia.
Ytre-Arne K; Nordøy A
J Intern Med; 1989 Nov; 226(5):285-90. PubMed ID: 2681508
[TBL] [Abstract][Full Text] [Related]
4. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
[TBL] [Abstract][Full Text] [Related]
5. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
Geisel J; Oette K; Burrichter H
Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.
Mölgaard J; von Schenck H; Olsson AG
Eur J Clin Pharmacol; 1989; 36(5):455-60. PubMed ID: 2502417
[TBL] [Abstract][Full Text] [Related]
7. [Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia].
Aubert I; Emmerich J; Charpak Y; Chanu B; Dachet C; Herlich D; Besseau M; Rouffy J; Jacotot B
Presse Med; 1988 May; 17(18):901-4. PubMed ID: 2968595
[TBL] [Abstract][Full Text] [Related]
8. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
O'Brien RC; Simons LA; Clifton P; Cooper ME; Jennings GL; Jerums G; Nestel PJ; Sullivan D
Med J Aust; 1990 May; 152(9):480-3. PubMed ID: 2199801
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemia.
Mölgaard J; Lundh BL; von Schenck H; Olsson AG
Atherosclerosis; 1991 Dec; 91 Suppl():S21-8. PubMed ID: 1789813
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia.
Wierzbicki AS; Lumb PJ; Cheung J; Crook MA
QJM; 1997 Oct; 90(10):631-4. PubMed ID: 9415344
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the addition of fenofibrate to the simvastatin-cholestyramine combination].
Schlienger JL
Presse Med; 1991 Mar; 20(12):565. PubMed ID: 1827899
[No Abstract] [Full Text] [Related]
12. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia.
Steinmetz A; Schwartz T; Hehnke U; Kaffarnik H
J Cardiovasc Pharmacol; 1996 Apr; 27(4):563-70. PubMed ID: 8847874
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of simvastatin (MK-733).
Stalenhoef AF; Mol MJ; Stuyt PM
Am J Med; 1989 Oct; 87(4A):39S-43S. PubMed ID: 2679083
[TBL] [Abstract][Full Text] [Related]
14. Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
Smit JW; Van Erpecum KJ; Portincasa P; Renooij W; Erkelens DW; Van Berge-Henegouwen GP
Gut; 1995 Nov; 37(5):654-9. PubMed ID: 8549941
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.
Leclercq V; Harvengt C
Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia.
Mol MJ; Erkelens DW; Gevers Leuven JA; Schouten JA; Stalenhoef AF
Atherosclerosis; 1988 Feb; 69(2-3):131-7. PubMed ID: 3279966
[TBL] [Abstract][Full Text] [Related]
17. One year experience in the treatment of familial hypercholesterolaemia with simvastatin.
Quiney J; Watts GF; Kerr-Muir M; Slavin B; Lewis B
Postgrad Med J; 1992 Jul; 68(801):575-80. PubMed ID: 1437957
[TBL] [Abstract][Full Text] [Related]
18. Low-density-lipoprotein apheresis.
Olbricht CJ
Lancet; 1995 Jul; 346(8967):116; author reply 117. PubMed ID: 7603187
[No Abstract] [Full Text] [Related]
19. Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome.
Rabelink AJ; Hené RJ; Erkelens DW; Joles JA; Koomans HA
Lancet; 1988 Dec; 2(8624):1335-8. PubMed ID: 2904053
[TBL] [Abstract][Full Text] [Related]
20. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
Mol MJ; Stuyt PM; Demacker PN; Stalenhoef AF
Neth J Med; 1990 Apr; 36(3-4):182-90. PubMed ID: 2355995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
